Development of a PET Probe Targeting Bromodomain and Extra-Terminal Proteins for In Vitro and In Vivo Visualization
<b>Background:</b> Bromodomain and extra-terminal (BET) proteins are critical regulators of gene transcription, as they recognize acetylated lysine residues. The BD1 bromodomain of BRD4, a member of the BET family, has emerged as a promising therapeutic target for various diseases. This...
Saved in:
Main Authors: | Yongle Wang, Yanli Wang, Yulong Xu, Hua Cheng, Tewodros Mulugeta Dagnew, Leyi Kang, Darcy Tocci, Iris Z. Shen, Can Zhang, Changning Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-12-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | https://www.mdpi.com/1424-8247/17/12/1670 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Bromodomain proteins as potential therapeutic targets for B-cell non-Hodgkin lymphoma
by: Dan Zou, et al.
Published: (2024-11-01) -
Construction of the bromodomain-containing protein-associated prognostic model in triple-negative breast cancer
by: Wei Chen, et al.
Published: (2025-01-01) -
Potential of non-FDG PET radiotracers for paediatric patients with solid tumours
by: Leonor Teles, et al.
Published: (2024-12-01) -
Docking‑based virtual screening of BRD4 (BD1) inhibitors: assessment of docking methods, scoring functions and in silico molecular properties
by: Junmin Dong, et al.
Published: (2024-12-01) -
Targeting BRD4 ameliorates experimental emphysema by disrupting super-enhancer in polarized alveolar macrophage
by: Difei Li, et al.
Published: (2025-01-01)